{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T16:03:57Z","timestamp":1794326637839,"version":"4.9.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010390","name":"Saint Louis University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010390","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartandlung.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart & Lung"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.hrtlng.2026.102752","type":"journal-article","created":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T10:55:19Z","timestamp":1772362519000},"page":"102752","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Risk of acute myocardial infarction with ticagrelor, prasugrel, and clopidogrel prescription after coronary stent restenosis: A retrospective real-world comparative risk analysis with TriNetX"],"prefix":"10.1016","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-4218-3218","authenticated-orcid":false,"given":"Yesh V","family":"Dhruva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhil V","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atman K","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit B","family":"Ponnada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Mootz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Hsien","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkata Praneeth","family":"Peddada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Jung","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.hrtlng.2026.102752_bib0001","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJMra1210816","article-title":"Drug-eluting coronary-artery stents","volume":"368","author":"Stefanini","year":"2013","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.hrtlng.2026.102752_bib0002","article-title":"Clinical impact of suboptimal stenting and residual intrastent plaque\/thrombus protrusion in patients with acute coronary syndrome: the CLI-OPCI ACS substudy","volume":"9","author":"Prati","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"issue":"33","key":"10.1016\/j.hrtlng.2026.102752_bib0003","first-page":"2550","article-title":"Understanding and managing in-stent restenosis: a review of clinical data, pathophysiology, and emerging treatment options","volume":"37","author":"Buccheri","year":"2016","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.hrtlng.2026.102752_bib0004","first-page":"142","article-title":"Coronary in-stent restenosis: mechanisms, diagnosis and management","volume":"90","author":"Alfonso","year":"2004","journal-title":"Heart"},{"issue":"10","key":"10.1016\/j.hrtlng.2026.102752_bib0005","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1161\/CIR.0000000000000404","article-title":"2016 ACC\/AHA Guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease","volume":"134","author":"Levine","year":"2016","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.hrtlng.2026.102752_bib0006","first-page":"1033","article-title":"Dual antiplatelet therapy following percutaneous coronary intervention: clinical and economic impact of standard versus extended duration","volume":"22","author":"Wells","year":"2019","journal-title":"Value Health"},{"issue":"6","key":"10.1016\/j.hrtlng.2026.102752_bib0007","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jacc.2013.09.043","article-title":"Short- versus long-term duration of dual antiplatelet therapy in patients treated for in-stent restenosis: a PRODIGY Trial Substudy","volume":"63","author":"Campo","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.hrtlng.2026.102752_bib0008","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/cpt.2797","article-title":"Comparative effectiveness of ticagrelor, prasugrel, and clopidogrel for secondary prophylaxis in acute coronary syndrome: a propensity score-matched cohort study","volume":"113","author":"Kumar","year":"2023","journal-title":"Clin Pharmacol Ther"},{"issue":"14","key":"10.1016\/j.hrtlng.2026.102752_bib0009","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.jacc.2006.11.044","article-title":"Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives","volume":"49","author":"Angiolillo","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.hrtlng.2026.102752_bib0010","doi-asserted-by":"crossref","first-page":"ooad035","DOI":"10.1093\/jamiaopen\/ooad035","article-title":"A global federated real-world data and analytics platform for research","volume":"6","author":"Palchuk","year":"2023","journal-title":"JAMIA Open"},{"issue":"11","key":"10.1016\/j.hrtlng.2026.102752_bib0011","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.hrtlng.2026.102752_bib0012","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.hrtlng.2026.102752_bib0013","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s40256-019-00373-1","article-title":"Efficacy and safety of clopidogrel, prasugrel and ticagrelor in ACS Patients Treated With PCI: a propensity score analysis of the RENAMI and BleeMACS registries","volume":"20","author":"Peyracchia","year":"2020","journal-title":"Am J Cardiovasc Drugs"},{"issue":"4","key":"10.1016\/j.hrtlng.2026.102752_bib0014","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/clc.23536","article-title":"Effects of clopidogrel, prasugrel and ticagrelor on prevention of stent thrombosis in patients undergoing percutaneous coronary intervention: a network meta-analysis","volume":"44","author":"Chen","year":"2021","journal-title":"Clin Cardiol"},{"issue":"1","key":"10.1016\/j.hrtlng.2026.102752_bib0015","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1097\/MJT.0000000000000350","article-title":"Comparative efficacy and safety of prasugrel, ticagrelor, and standard-dose and high-dose clopidogrel in patients undergoing percutaneous coronary intervention: a network meta-analysis","volume":"23","author":"Singh","year":"2016","journal-title":"Am J Ther"},{"issue":"25","key":"10.1016\/j.hrtlng.2026.102752_bib0016","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1161\/CIRCULATIONAHA.109.912550","article-title":"Randomized double-blind assessment of the onset and offset of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET\/OFFSET study","volume":"120","author":"Gurbel","year":"2009","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.hrtlng.2026.102752_bib0017","first-page":"700","article-title":"Impact of chronic ticagrelor use on clinical outcomes and adherence in patients with acute coronary syndromes: a meta-analysis","volume":"91","author":"Giannini","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"issue":"5","key":"10.1016\/j.hrtlng.2026.102752_bib0018","first-page":"5236","article-title":"Ticagrelor shows greater platelet inhibition but more variable pharmacodynamic response compared with prasugrel: a randomized head-to-head comparison","volume":"168","author":"Park","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrtlng.2026.102752_bib0019","article-title":"Oral P2Y12 inhibitors: victims or perpetrators?","author":"Bigagli","year":"2025","journal-title":"Clinically Relevant Drug. Radcliffe Cardiology. Published"},{"key":"10.1016\/j.hrtlng.2026.102752_bib0020","article-title":"Doubts over landmark heart drug trial: ticagrelor PLATO study","volume":"387","author":"Doshi","year":"2024","journal-title":"BMJ"}],"container-title":["Heart & Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147956326000361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147956326000361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T20:42:27Z","timestamp":1784666547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0147956326000361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":20,"alternative-id":["S0147956326000361"],"URL":"https:\/\/doi.org\/10.1016\/j.hrtlng.2026.102752","relation":{},"ISSN":["0147-9563"],"issn-type":[{"value":"0147-9563","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of acute myocardial infarction with ticagrelor, prasugrel, and clopidogrel prescription after coronary stent restenosis: A retrospective real-world comparative risk analysis with TriNetX","name":"articletitle","label":"Article Title"},{"value":"Heart & Lung","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrtlng.2026.102752","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102752"}}